Skyrizi 360 MG/2.4 ML on-body 2.4ML
Ended Awarded
- Contract number
- SPE2DR26F8ZLC
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,467
Award facts
- Contract value 100% obligated
- $12,467.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order award valued at $12,467.00 from the Defense Logistics Agency (DLA) on November 12, 2025, for the supply of Skyrizi 360 mg/2.4 mL on-body injector units. This firm fixed-price delivery order, with an ultimate completion date of December 4, 2025, was competitively awarded without set-aside provisions and will be performed at the contractor's corporate office location in Conshohocken, PA. Skyrizi is a biologic medication used in the treatment of inflammatory skin conditions, reflecting the pharmaceutical distributor's role in supplying specialized medical products to federal healthcare systems.
This delivery order operates under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 through December 2026. This comprehensive global pharmaceutical support vehicle enables the contractor to supply an extensive portfolio of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including deliveries to the Defense Health Agency and U.S. Coast Guard. The contractor's demonstrated capability to fulfill federal medical procurement requirements through open competition, combined with its established IDC framework, positions it as a critical vendor within the DLA's medical supply chain infrastructure.
Quick answers
Who was awarded contract SPE2DR26F8ZLC?
SPE2DR26F8ZLC was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 12, 2025.
How much is contract SPE2DR26F8ZLC worth?
The government has obligated $12,467 on SPE2DR26F8ZLC.
Is contract SPE2DR26F8ZLC an order under another contract?
Yes. SPE2DR26F8ZLC is a delivery order under SPE2DR25D1017, an indefinite delivery contract.
Was contract SPE2DR26F8ZLC competed?
The extent of competition for SPE2DR26F8ZLC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award